Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments
The possibility of rational design and the resulting faster and more cost-efficient development cycles of nucleic acid–based therapeutics (NBTs), such as antisense oligonucleotides, siRNAs, and gene therapy vectors, have fueled increased activity in developing therapies for orphan diseases. Despite...
Main Authors: | Olga Khorkova, Jane Hsiao, Claes Wahlestedt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.643681/full |
Similar Items
-
Nucleic acid-based therapeutics for the treatment of central nervous system disorders
by: Robyn McCartan, et al.
Published: (2023-08-01) -
Recent Advances in Oligonucleotide Therapeutics in Oncology
by: Haoyu Xiong, et al.
Published: (2021-03-01) -
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
by: Jun Wei, et al.
Published: (2021-08-01) -
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
by: Chisato Terada, et al.
Published: (2022-11-01) -
Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
by: Hiroki Tanaka, et al.
Published: (2021-04-01)